Goldman Sachs Group Inc Tela Bio, Inc. Transaction History

Goldman Sachs Group Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$4.39 - $6.36 $619,604 - $897,650	141,140 Added 1119.36%	153,749 $722,000
Q1 2024 May 15, 2024	BUY	$5.3 - $7.61 $66,827 - $95,954	12,609 New	12,609 $71,000
Q1 2023 May 14, 2024	BUY	$9.41 - $12.03 $330,808 - $422,914	35,155 New	35,155 $374,000
Q1 2023 May 11, 2023	BUY	$9.41 - $12.03 $330,808 - $422,914	35,155 New	35,155 $374,000
Q1 2022 May 16, 2022	SELL	$11.35 - $13.7 $223,163 - $269,369	-19,662 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$11.95 - $13.34 $42,518 - $47,463	-3,558 Reduced 15.32%	19,662 $252,000
Q3 2021 Nov 10, 2021	BUY	$12.2 - $15.93 $283,284 - $369,894	23,220 New	23,220 $317,000

18.3M

759K

100

Ticker TELA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 19,157,600
Market Cap $53.4M
Description
TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. It provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall recon...

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

Stay updated on Goldman Sachs Group Inc with notifications on news.